In this study, we discovered that lactate-derived H3K18la is a critical factor for inducing the expression and oncogenic activity of KRT19, and intervention of KRT19 potently promotes p21-driven senescence program in NSCLC cells and boosts anti-PD-1 immunotherapy efficiency. The gene discussed is CDKN1A; the disease is non-small cell lung carcinoma.